Targeting autophagy in lymphomas: a double-edged sword?
- PMID: 29380180
- DOI: 10.1007/s12185-018-2414-6
Targeting autophagy in lymphomas: a double-edged sword?
Abstract
Autophagy (also known as macroautophagy) is a lysosomal degradation pathway for the clearance of cellular materials, which manifests as an adaptive response to stress stimuli. Over the past decade, numerous studies have linked autophagy with cancer initiation, progression, and chemoresistance. Autophagy defects in normal cells facilitate tumorigenesis; paradoxically, enhanced autophagy allows prolonged survival in cancer cells upon nutrient shortage, low oxygen, or chemotherapies. However, the mechanism underlying the switch from the cytoprotective role of autophagy to autophagic cell death remains incompletely understood. Here, I review the latest advances in understanding the role of autophagy in lymphomas, current challenges, and future directions.
Keywords: Autophagy; Cell death; Cell survival; Chemotherapy; Lymphoma.
Similar articles
-
Autophagy in disease: a double-edged sword with therapeutic potential.Clin Sci (Lond). 2009 May;116(9):697-712. doi: 10.1042/CS20080508. Clin Sci (Lond). 2009. PMID: 19323652 Review.
-
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications.Biochim Biophys Acta. 2015 Jan;1853(1):14-26. doi: 10.1016/j.bbamcr.2014.09.023. Epub 2014 Oct 2. Biochim Biophys Acta. 2015. PMID: 25284725 Review.
-
Pro-survival autophagy and cancer cell resistance to therapy.Cancer Metastasis Rev. 2018 Dec;37(4):749-766. doi: 10.1007/s10555-018-9727-z. Cancer Metastasis Rev. 2018. PMID: 29536228 Review.
-
Life, death and burial: multifaceted impact of autophagy.Biochem Soc Trans. 2008 Oct;36(Pt 5):786-90. doi: 10.1042/BST0360786. Biochem Soc Trans. 2008. PMID: 18793137 Review.
-
Modulating autophagy in cancer therapy: Advancements and challenges for cancer cell death sensitization.Biochem Pharmacol. 2018 Jan;147:170-182. doi: 10.1016/j.bcp.2017.11.021. Epub 2017 Dec 2. Biochem Pharmacol. 2018. PMID: 29203368 Review.
Cited by
-
Drug Resistance in Non-Hodgkin Lymphomas.Int J Mol Sci. 2020 Mar 18;21(6):2081. doi: 10.3390/ijms21062081. Int J Mol Sci. 2020. PMID: 32197371 Free PMC article. Review.
-
Non‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells.Oncol Rep. 2019 May;41(5):2803-2817. doi: 10.3892/or.2019.7040. Epub 2019 Mar 1. Oncol Rep. 2019. PMID: 30864717 Free PMC article.
-
The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors.Cells. 2018 Dec 20;8(1):4. doi: 10.3390/cells8010004. Cells. 2018. PMID: 30577555 Free PMC article. Review.
-
Chaetomugilin J Enhances Apoptosis in Human Ovarian Cancer A2780 Cells Induced by Cisplatin Through Inhibiting Pink1/Parkin Mediated Mitophagy.Onco Targets Ther. 2020 Oct 7;13:9967-9976. doi: 10.2147/OTT.S273435. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116582 Free PMC article.
-
Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.Cancer Sci. 2021 Apr;112(4):1589-1602. doi: 10.1111/cas.14833. Epub 2021 Feb 16. Cancer Sci. 2021. PMID: 33525055 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous